Literature DB >> 9544423

Therapy of cancer metastasis by activation of the inducible nitric oxide synthase.

K Xie1, I J Fidler.   

Abstract

The process of cancer metastasis consists of multiple sequential and highly selective steps. The vast majority of tumor cells that enter the circulation die rapidly; only a few survive to produce metastases. This survival is not random. Metastases are clonal in origin and are produced by specialized subpopulations of cells that preexist in a heterogeneous primary tumor. Experimental studies concluded that metastatic cells survive in the circulation whereas nonmetastatic cells do not. In part, this difference is due to an inverse correlation between expression of endogenous inducible nitric oxide synthase (iNOS) and production of nitric oxide (NO) and metastatic potential. Direct evidence for the role of iNOS in metastasis has been provided by our data on transfection of highly metastatic murine K-1735 clone 4 (C4.P) cells which express low levels of iNOS, with a functional iNOS (C4.L8), inactive mutated iNOS (C4.S2), or neomycin resistance (C4.Neo) genes in medium containing 3 mM of the specific iNOS inhibitor NG-L-methyl arginine (NMA). C4.P, C4.Neo, and C4.S2 cells were highly metastatic, whereas C4.L8 cells were not. Moreover, C4.L8 cells produced slow-growing subcutaneous tumors in nude mice, whereas the other 3 cell lines produced fast-growing tumors. In vitro studies indicated that the expression of iNOS in C4.L8.5 cells was associated with either cytostasis or cytolysis via apoptosis, depending upon NO output. The tumor cells producing high levels of NO underwent autocytolysis and produced cytolysis of bystander cells under both in vitro and in vivo conditions. Multiple i.v. injections of liposomes containing a synthetic lipopeptide upregulated iNOS expression in murine M5076 reticulum sarcoma cells growing as hepatic metastases. The induction of iNOS was associated with the complete regression of the lesions. Transfection of interferon-beta suppressed tumor formation and eradicated metastases, which was apparently linked to iNOS expression and NO production in host cells such as macrophage. Besides mediating cell death, NO produced tumor suppression by regulating expression of genes related to metastasis, e.g., survival, invasion, and angiogenesis. Suppression of metastasis can be achieved through use of immunomodulators that induce iNOS expression in tumor lesions or by the direct delivery of the iNOS gene to tumor cells or host cells through liposome and/or viral vectors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9544423     DOI: 10.1023/a:1005956721457

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  37 in total

1.  Characterization of C-alkyl amidines as bioavailable covalent reversible inhibitors of human DDAH-1.

Authors:  Matthew Lluis; Yun Wang; Arthur F Monzingo; Walter Fast; Jon D Robertus
Journal:  ChemMedChem       Date:  2011-01-03       Impact factor: 3.466

2.  Expression profiling and interferon-beta regulation of liver metastases in colorectal cancer cells.

Authors:  Regis Zimmer; Peter Thomas
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

3.  Apoptosis, angiogenesis, inflammation, and oxidative stress: basic interactions in patients with early and metastatic breast cancer.

Authors:  Enas A Hamed; Madeha M Zakhary; Doaa W Maximous
Journal:  J Cancer Res Clin Oncol       Date:  2012-02-24       Impact factor: 4.553

Review 4.  Nitric oxide and angiogenesis.

Authors:  M Ziche; L Morbidelli
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

5.  Inhibition by vasoactive intestinal polypeptide (VIP) of angiogenesis induced by murine Colon 26-L5 carcinoma cells metastasized in liver.

Authors:  M Ogasawara; J Murata; Y Kamitani; K Hayashi; I Saiki
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

6.  Plasma bcl-2 and nitric oxide: possible prognostic role in patients with metastatic breast cancer.

Authors:  H E Gaballah; I Abdel Salam; N Abdel Wahab; O M Mansour
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

7.  A novel, clinically relevant animal model of metastatic pancreatic adenocarcinoma biology and therapy.

Authors:  B Wang; Q Shi; J L Abbruzzese; Q Xiong; X Le; K Xie
Journal:  Int J Pancreatol       Date:  2001

Review 8.  Mouse models of metastatic pancreatic adenocarcinoma.

Authors:  K Xie; B Wang; Q Shi; J L Abbruzzese; Q Xiong; X Le
Journal:  Int J Pancreatol       Date:  2001

Review 9.  Revisiting the seed and soil in cancer metastasis.

Authors:  Martin Mendoza; Chand Khanna
Journal:  Int J Biochem Cell Biol       Date:  2009-02-03       Impact factor: 5.085

10.  Production of nitric oxide and expression of inducible nitric oxide synthase in ovarian cystic tumors.

Authors:  Rosekeila Simões Nomelini; Lívia Carolina de Abreu Ribeiro; Beatriz Martins Tavares-Murta; Sheila Jorge Adad; Eddie Fernando Candido Murta
Journal:  Mediators Inflamm       Date:  2009-01-05       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.